Furthermore, participants with elevated CEA and hepatic steatosis (group 4) had higher risk of developing IHD compared to those with low CEA and no hepatic steatosis (group 1) (hazard ratio: 1.63, 95% confidence interval: 1.04–2.55, p = 0.034). This evidence concerns the gene CEACAM5 and fatty liver disease.